Similar Papers

Paper Title
Journal
Date
Author
Acute lymphoblastic leukemia in adolescents and young adults – from genomics to the clinics
Mark Litzow ... Kenderian
Clinical Oncology in Adolescents and Young Adults | VOL. 3
Mark Litzow, et. al.Mark Litzow ... Kenderian
01 Apr 2013
A Genome-Wide Association Study of Susceptibility to Acute Lymphoblastic Leukemia in Adolescents and Young Adults
...
Blood | VOL. 124
, et. al. ...
06 Dec 2014
Treatment strategy for acute lymphoblastic leukemia in adolescent and young adults
Etsuko Yamazaki
[Rinsho ketsueki] The Japanese journal of clinical hematology | VOL. 63
Etsuko YamazakiEtsuko Yamazaki
01 Jan 2021
Comparable Outcomes of Relapsed Acute Lymphoblastic Leukemia in Adolescents and Young Adults (AYA) Patients Treated with Pediatric-Inspired Chemotherapy (R3 protocol) Versus Adult-Based Salvage (FA) Protocol
Chokri Ben Lamine ... Amr Hanbali
Blood | VOL. 142
Chokri Ben Lamine, et. al.Chokri Ben Lamine ... Amr Hanbali
28 Nov 2023
View more papers

More From: Clinical Lymphoma, Myeloma and Leukemia

Paper Title
Journal
Date
Author
SOHO State of the Art Updates and Next Questions | Venetoclax + Obinutuzumab Therapy in Chronic Lymphocytic Leukemia
Andrew H Lipsky ... Nicole Lamanna
Clinical Lymphoma, Myeloma and Leukemia | VOL. -
Andrew H Lipsky, et. al.Andrew H Lipsky ... Nicole Lamanna
01 Dec 2024
Table of Contents
-
Clinical Lymphoma, Myeloma and Leukemia | VOL. 24
--
01 Dec 2024
A phase I study of romidepsin in combination with gemcitabine, oxaliplatin, and dexamethasone in patients with relapsed or refractory aggressive lymphomas enriched for T-cell lymphomas.
Nicole Foley ... Neha Mehta-Shah
Clinical Lymphoma, Myeloma and Leukemia | VOL. -
Nicole Foley, et. al.Nicole Foley ... Neha Mehta-Shah
01 Dec 2024
Editorial Board
-
Clinical Lymphoma, Myeloma and Leukemia | VOL. 24
--
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.